z-logo
open-access-imgOpen Access
The effect of alpha blockers on uroflowmetric parameters in different voiding positions
Author(s) -
Gökhan Koç,
Yılmaz Yüksel,
Sıtkı Ün,
Kaan Akbay,
F. Akdeniz
Publication year - 2013
Publication title -
canadian urological association journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.477
H-Index - 38
eISSN - 1920-1214
pISSN - 1911-6470
DOI - 10.5489/cuaj.1250
Subject(s) - sitting , medicine , hyperplasia , urology , supine position , residual volume , position (finance) , ultrasonography , surgery , lung volumes , finance , pathology , lung , economics
We assessed the effect of different voiding positionson uroflowmetric parameters and post-void residual (PVR)urine volume in symptomatic benign prostatic hyperplasia (BPH)patients. We also evaluated the effect of alpha blockers on PVR indifferent voiding positions.Methods: The study was performed with 110 BPH patients over 50years old. In total, 4 uroflowmetries were performed in all patients:2 patients in the sitting position and 2 in the standing position. PVRwas measured with transabdominal ultrasonography. Also, patientswere divided into two groups according to the alpha adrenergicblocker treatment; the effect of this treatment on their uroflowmetricparameters in different positions was evaluated.Results: Maximum flow rate (Qmax) and average flow rate (Qave)were significantly higher in patients in the sitting position, butthere were no differences in other uroflowmetric parameters andPVR volume (Qmax: 15.5±5.9 mL/s vs. 13.7±5.2 mL/s, Qave:11.4±4.6 mL/s vs. 10.7± 3.9 mL/s, respectively; p < 0.05). TheQmax and Qave were significantly higher in sitting position, comparedto the standing position, in both alpha adrenergic treatmentand non-treated groups; again, there were no differences in otheruroflowmetric parameters and PVR volume.Conclusion: Qmax and Qave values were significantly higher inthe sitting position. Alpha blockers did not affect any change.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here